Here are the Assessment of basic pharmacokinetic parameters of dapagliflozin in TTS formulations in male minipigs journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.
Assessment of basic curricular skills, assessment of basic pharmacokinetic equations, wiig assessment of basic concepts, global assessment of functioning, assessment of basic pharmacokinetic concepts, assessment of basic pharmacokinetic parameters of circle.
Assessment of basic pharmacokinetic parameters of dapagliflozin in TTS formulations in male minipigs
Given the extended time over which diabetes treatment is administered, the transdermal delivery system is anticipated to be a more suitable option for older individuals who may experience difficulty swallowing. The continuous delivery of dapagliflozin and more stable plasma levels are anticipated to reduce the incidence of side effects and the frequency of dosing. The objectives of the study were to determine the safety and plasma pharmacokinetics of dapagliflozin in male minipigs following application of the ointment and skin patch. In the initial phase of the study, the potential for transdermal permeation of dapagliflozin from ointment and transdermal patch to blood plasma of 15 male Göttingen minipigs was investigated. In the subsequent phase, the efficacy of utilising patches of varying strengths and sizes was assessed. The LC/MS method was employed to quantify the concentration of the active substance. The transportation of the studied API to the general circulation an d accumulation in tissues were confirmed. The maximum drug concentration (122.99 ng/mL) in plasma was observed on the fourth day of application. The highest calculated Cmax was 131.91 ng/mL with a mean AUC0-last of 6620.7 ng h/mL. Following transdermal administration, dapagliflozin is excreted in the urine. The trend between urinary dapagliflozin 3-O-glucuronide levels and urinary glucose excretion was also observed. The transdermal patch has been demonstrated to be an effective drug delivery system for dapagliflozin. © The Author(s) 2024.
Authors : Paweł B.; Balwierz R.; Mieszko D.; Mikołaj K.; Micewicz E.; Dawid B.; Pogorzelec Ł.
Source : Nature Research
Article Information
| Year | 2024 |
| Type | Article |
| DOI | 10.1038/s41598-024-74675-z |
| ISSN | 20452322 |
| Volume | 14 |
You can download the article here
If You have any problem, contact us here